Max Rady College of Medicine
Last Updated: 2005-11-28
A method of protecting the intangible asset generated through research processes. It creates a temporary, state-conferred monopoly over the sale of a product by prohibiting the unlicensed entry of competitors.
- Morgan SG, Kozyrskyj A, Metge C, Roos NP. Pharmaceuticals: Therapeutic interchange and pricing policies. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary] (View)
Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada